key: cord-0054982-lac3q3u1
authors: Arya, Sagar S.; Rookes, James E.; Cahill, David M.; Lenka, Sangram K.
title: Vanillin: a review on the therapeutic prospects of a popular flavouring molecule
date: 2021-01-07
journal: ADV TRADIT MED (ADTM)
DOI: 10.1007/s13596-020-00531-w
sha: 102c85dbce65e6449d742bf772bc54553a346f17
doc_id: 54982
cord_uid: lac3q3u1

ABSTRACT: Vanilla is the world’s most popular flavour extracted from the pods of Vanilla planifolia orchid. It is a mixture of ~ 200 compounds but its characteristic flavour and fragrance primarily come from vanillin. While the importance of its wide usage in flavour and fragrance is well established, there have been limited investigations to evaluate its bioactive potential. However, a few studies have reported a promising array of bioactivities that could be exploited for multiple therapeutic applications. Recently, bioactive properties of vanillin, such as neuroprotection, anticarcinogenic, and antioxidant are gaining attention. Besides this, vanillin and its synthetic analogues are found to regulate gene expression and exhibit biological activities. Therefore, here we summarize the potential bioactivates of vanillin and its derivative with an aim to change the perspective from being a popular flavour to a new age therapeutics molecule. GRAPHIC ABSTRACT: [Image: see text]

Vanilla is arguably the world's most popular flavour and is derived from mature pods of the orchid Vanilla planifolia. It constitutes one of the most preferred flavours and fragrance ingredients in ice-creams, confectioneries, milk products, perfumes, pharmaceuticals, liqueur and other cordial industries, thereby forming a whopping multimillion-dollar market (Gallage and Møller 2018) . For centuries vanilla flavour remained classified for the rest of the world since it was ascribed as a flavour of nobility by Aztecs and pre-Columbian Mayas. It was in 1519 that vanilla was exposed to the world with the Spanish invasion of the Aztecs. It was transported to Europe and subsequent development of hand pollination techniques led to its expansion to other parts of the world (Teoh 2019) . Today, Madagascar is the largest producer of natural vanilla with 75% of world production followed by Indonesia, China, Mexico, and Papua New Guinea. Vanilla is a mixture of ~ 200 compounds; however, it's characteristic flavour and fragrance comes mainly from the molecule vanillin (Gallage and Møller 2018) .

Vanillin is a specialized metabolite and the main ingredient of vanilla extract that occurs in concertation of 1.0-2.0% w/w in cured vanilla beans (Zhang and Mueller 2012) . Vanillin has different functional groups, like aldehyde, hydroxyl and ether attached to an aromatic ring. The physicochemical properties of vanillin are described in Table 1 . Vanillin is either isolated from vanilla extract or is chemically synthesized from guaiacol. Besides being known for flavour and fragrance, it has diverse bioactive properties, namely anticancer, neuroprotective, antibiotic potentiation, and anti-quorum sensing (Arya et al. 2019; Bezerra et al. 2016; Li et al. 2018) . Moreover, the bioactivities of curcumin are now attributed to the constituent and stable degradation products, i.e. vanillin and ferulic acid (Iannuzzi et al. 2017) . Though recent studies on vanillin have eluded to its bioactive potential, in comparison to curcumin the level of research activity is very limited. Therefore, due to the potential emerging reports of usage of vanillin as a therapeutic molecule and its inclusion in the food additive on generally regarded as safe (GRAS) list, it is an ideal candidate for health care applications (Tai et al. 2011b) . Our focus here is to provide an in-depth look at the bioactive properties of vanillin (Table 2) as an attempt to identify it as a mainstream bioactive small molecule like curcumin. Readers are also directed to the reviews by Singletary (2020) , Sharma et al. (2020) , Anand et al. (2019) and Bezerra-Filho et al. (2019) that highlighted the therapeutic use of vanilla, vanillin, and vanillic acid.

The literature for this review was extracted from the last three decades published in various research and review articles, book chapters, and conference proceedings. The search engines used to search this information includes PubMed, Google Scholar, Science direct and ScopeMed. The keywords or search terms, "vanillin", "vanillin derivatives, bioactivities, anticancer, antioxidant, anti-inflammatory, neuroprotective, anti-sickling, anti-amyloid aggregation and inhibition of non-enzymatic glycation, antibacterial, anti-fungal, anti-quorum sensing, antibiotic potentiation, wound healing/tissue engineering, antiviral", "toxicity", "nanoparticles", "nanocarriers" and their combination were used (Fig. 1 ).

Typically, there are three sources of vanillin, i.e. natural, chemical/synthetic and biotechnological (Fig. 2) . Depending on the source and the synthesis procedure, the vanillin is categorized as either natural or artificial flavour. Of these, the natural and biotechnologically produced vanillin (from ferulic acid as a substrate) is considered as foodgrade additives by most food control authorities across the world.

Vanillin is naturally extracted from vanilla pod extract of Vanilla planifolia, Vanilla tahitensis, and Vanilla pompona which are by far the main sources of vanillin (Bezerra et al. 2016) . Commercial extraction methods for vanillin include Soxhlet, supercritical fluid extraction (SCEF), microwave and ultrasound-assisted extraction, enzymatic extraction, solid-phase extraction and biphasic sonoelectroanalysis (Hardcastle et al. 2001; Kun 2002; Sharma et al. 2006; Sostaric et al. 2000; Voisine et al. 1995; Waliszewski et al. 2007 ). Natural vanillin is the most expensive form at a cost of nearly US$ 1200/kg to more than US$ 4000/kg (Gallage and Møller 2018) .

Compared to the natural source, chemically synthesized vanillin it is considerably cheaper ($15/kg), however, is labeled as artificial vanillin which attracts negative consumer sentiments. Various substrates have been tried for the synthesis of synthetic vanillin, like lignin, guaiacol, 4-hydroxybenzaldeyde, 3-bromo-4-hydroxybenzaldeyde, 3-methoxy-4-hydroxybenzyl alcohol, cow dung and lignin-rich crop residual waste materials with varying success (Banerjee and Chattopadhyay 2019; Ciriminna et al. 2019 ).

Bioengineering is a modern route for the production of vanillin. Various proprietary bacterial and fungal strains are genetically engineered that use a spectrum of starting materials like ferulic acid, eugenol, iso-eugenol and glucose. Also, enzymatic synthesis of vanillin using proteins from Nocardia sp. and white-rot basidiomycetes have been reported (Banerjee and Chattopadhyay 2019). Furthermore, genetically engineered plants or plant cell cultures producing vanillin are proposed as a future alternative to produce vanillin and increase its commercial and medical applicability (Chee et al. 2017 ).

As a popular flavour and fragrance compound, vanillin has received less attention for the bioactive properties it possesses. However, to be used as a pharmaceutical ingredient, it must have the desired bioactivity and should be bioavailable in humans and/or animals. In this regard, bioavailability studies have identified the rate and concentration at which vanillin is absorbed in the blood, plasma and also its target site (Beaudry et al. 2010) . It is shown that vanillin has an LD50 (lethal dose to kill half of a tested population) of 4333 mg/kg for mice and 4730 mg/kg for rats (Makaruk 1980) . Furthermore, toxicology studies on rats via oral and intraperitoneal administration of vanillin confirms that it is safe even at a high concentration of 300 mg/kg and did not exhibit any toxic effect on kidney, liver, blood cells, and also showed blood and neuroprotective properties (Ho et al. 2011) . Owing to its non-toxicity in rats, it is worthwhile to consider vanillin as a candidate bioactive molecule and highlight its potential pharmacological applicability.

Reports that implicate vanillin in mediation of DNA damage and antimutagenic potential have encouraged researchers to evaluate the anticancer effects at cellular and molecular levels (Bezerra et al. 2016) . Vanillin (1000 µg/mL) inhibited the proliferation of HT-29 cells (Colon cancer cells) where significant cell arrest occurred during the G0/G1 phase and an increase in apoptotic cells in sub-G0 phase was observed (Ramadoss and Sivalingam 2019) . Further, a derivative of vanillin, 4-(1H-imidazo [4,5-f] [1,10]-phenanthrolin-2-yl)-2-methoxyphenol (IPM711) showed growth inhibition, invasion and migration of HT-29 and HCT116 cells by binding to a Wnt/β-catenin signalling receptor . In this study, vanillin down-regulated proteasome genes in colon tissues and significantly suppressed proteasome activity. Furthermore, at 10 mM it hindered the mitogen-activated protein kinase (MAPK) phosphorylation, reducing the number of granulocytes in colon tissue, proliferating cells and p65-positive cells. Amelioration of cancerous activity by vanillin might be associated with downregulation of the proteasome genes, MAPK pathway and nuclear factor-κB (Li et al. 2018) . A vanillin derivative VND3207 has shown a strong radio-protective effect in radiation-induced intestinal injury in mice ). VND3207 was found to alleviate the radiation injury in human lymphoblastoid cells by enhancing the expression of the catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs) which is an essential part of DNA double-strand break repair mechanism. Another in vitro study suggested that vanillin induces apoptosis in human hepatic carcinoma and neuroblastoma cells (Naz et al. 2018) . Further molecular docking reveals binding of vanillin to CAMKIV enzyme associated with cancer and neurodegenerative diseases. Also, monodimer of vanillin was found to decrease the metastatic potential of HepG2 cells by inhibiting FAK/PI3K/Akt signalling pathway (Jantaree et al. 2017) . With these leads, we can use a multiomics and modelling approach to more precisely identify the potential molecular targets of vanillin.

Vanillin is reported to be a potent scavenger of ROS as observed in multiple antioxidant assays like ORAC (oxygen radical absorbance capacity), ABTS + (2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid), and oxidative haemolysis inhibition where it operates by self-dimerization contributing to high reaction stoichiometry (Tai et al. 2011b) . Also, it is found to have anti-inflammatory activity, for instance, vanillin was found to inhibit nitric oxide in the lipopolysaccharide activated (LPA) RAW264.7 macrophages (Lim et al. 2008) . Moreover, suppression of inducible nitric oxide synthase (iNOS) is closely related to anti-inflammatory activity, RT-PCR studies revealed that vanillin concentration-dependently reduced the induction of iNOS mRNA in LPA macrophages.

Experimental evidence in animals has shown that vanillin acts as a neuroprotective agent in Huntington's disease (HD) and global ischemia (Gupta and Sharma 2014; Kim et al. 2007) . Vanillin significantly affected the 3-nitropropionic acid (3-NPA) induced HD in rats by attenuating motor coordination, learning-memory, locomotory and biochemical impairments (Gupta and Sharma 2014) . Moreover, vanillin (40 mg/kg) exhibited neuroprotection against neuronal cell damage in the hippocampal CA1 region (Kim et al. 2007 ).

Vanillin is further reported to promote early neurofunctional development, ameliorates histomorphological damage, brain infarct volume and brain edema after hypoxic-ischemic damage in neonatal rats (Lan et al. 2019 ). In spinal cord injury rat model, vanillin exerted neuroprotective effect reducing apoptosis and downregulating the expression of HIF-α in spinal tissues (Chen et al. 2019) . This neuroprotective effect of vanillin is proposed to be mediated by ROS scavenging, attenuating mitochondrial dysfunction, decreasing lipid peroxidation, and apoptosis (Dhanalakshmi et al. 2015) .

Recently, it was reported that vanillin and vanillic acid modulate antioxidant system via alleviation of metabolic complications linked to Fe 2+ -induced brain tissue damage (Salau et al. 2020 ). Thus, vanillin and its analogues can be further evaluated as a potential therapeutic agent for neuroprotection and stroke therapy.

Vanillin was evaluated as an agent to treat sickle cell disease (SCD) by Abraham et al. in 1991 . It showed dose-dependent inhibitory effect on deoxygenation (HbA) induced sickling and sickle haemoglobin (HbS) polymer formation with no adverse effect on cellular water or ionic content. Through X-ray crystallography, it is realized that binding of vanillin is near His 103α, Cys 104α and Gln 131β in central water cavity, with a secondary binding site at His 116β and His 117β (Abraham et al. 1991) . o-vanillin also affects the membrane permeability of red blood cells stimulating the efflux of K + ions which further ameliorated the complication of SCD (Hannemann et al. 2014) . Moreover, numerous vanillin derivatives have been developed which exhibit enhanced in vitro allosteric inhibition and anti-sickling as compared to vanillin (Pagare et al. 2018 ). Thus, vanillin or its derivatives can be designed and tested for allosteric modulation in stereospecific inhibition of HbS polymerization and highaffinity HbS.

Advanced glycation end products (AGE) are formed as end products of glycation reaction and are associated with developing sever diabetic complications that include neuropathy, nephropathy, retinopathy, and further progress in amyloid based neurodegenerative diseases. Vanillin was found to restrain NEG and AGE of albumin by functioning like a chemical chaperone (Awasthi and Saraswathi 2016) . This in vitro study provided preliminary evidence for vanillin mediated insulin glycation and amyloid aggregation and AGE formation by methyl-glyoxal was strongly reduced in the presence of vanillin. It is presumed that vanillin binds non-covalently to positively charged Arg22 of insulin B chain and hinder the glycation reaction (Iannuzzi et al. 2017) . Furthermore, vanillin also showed cytoprotective and anti-oxidant effect against AGE induced ROS products. These studies open new avenues for vanillin in the treatment of NEG and AGE induced diabetes.

Fungal pathogens are well known to affect food, human health and agriculture. It is found that vanillin can impede the growth of such fungal pathogens. For instance, vanillin (250 mg/L) decreased the growth of Alternaria strains, suggesting its fungistatic behaviour where the lag time of fungal life cycle was increased from initial 50 h to 112 h and also inhibition of mycelial growth of up to 37.5% was observed (Romero-Cortes et al. 2019) . Antifungal activity of vanillin and its 33 variants were tested against Cryptococcus neoformans which is the causative agent of cryoptococcal meningitis (Kim et al. 2014) . RNA-seq of o-vanillin and o-ethyl vanillin treated C. neoformans showed that they caused mitochondrial dysfunction and triggered oxidative stress, significantly reducing their growth. Omics based analysis of vanillin treated fungus may further reveal the molecular targets of vanillin and pave a way for its use as an antifungal molecule in food, agriculture and the pharmaceutical industry.

Vanillin was found to affect the growth of spoilage bacteria like Pantoea agglomerans, Aeromonas enteropelogenes, Micrococcus lylae and Sphingobacterium spiritovorun with the minimum inhibitory concentration (MIC) ranging from 10 to 13.3 mM (Ngarmsak et al. 2006) . It was found that exposure to 10-40 mM vanillin inhibited respiration of E. coli and Listeria innocua and treatment with 50-100 mM resulted in complete dissipation of proton ion gradient with loss of pH homeostasis in Lactobacillus plantarum (Fitzgerald et al. 2004) . In order to gain detailed insight into the cellular response to vanillin, the proteomics of vanillin treated E. coli showed that around 147 proteins exhibited a significant change in abundance in response to vanillin (Pattrick et al. 2019) . The treatment caused accumulation of ROS invoking adaptations mediated by a MarA, OxyR, and SoxS regulatory network and increased in RpoS/DksA-dependent gene expression. Also, AcrD and AaeAB were identified as potential vanillin efflux systems (Pattrick et al. 2019 ). Further omics-based studies are required for other pathogenic bacteria specially listed as critical threats by world health organization in order to identify novel gene/protein targets of vanillin in bacteria.

Vanillin at sub-inhibitory concentrations was found to modulate the activities of antibiotics. It was reported to regulate the activities of gentamycin, imipenem, norfloxacin and spectinomycin used against Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli (Bezerra et al. 2017; Brochado et al. 2018) . It also potentiated the activities of some commonly used and last line antibiotics like chloramphenicol, ciprofloxacin, levofloxacin, tigecycline, meropenem, trimethoprim and fosfomycin against extremely drug-resistant P. aeruginosa clinical isolates (Arya et al. 2019 (Arya et al. , 2020 . These studies suggest that vanillin has the potential to be used as an antibiotic adjuvant in future.

Bacteria either grow as planktonic cells or in films known as biofilms. These biofilms are highly resistant towards antibacterial agents and can be inhibited by anti-quorum sensing molecules that affect bacterial signalling. Reports on vanillin suggest that it can inhibit short-chain homoserine lactones and long-chain acyl-homoserine lactones in Aeromonas hydrophila (Ponnusamy et al. 2009 ). Recently, the in vitro analysis in P. aeruginosa and in silico docking studies revealed that vanillin binds to the active site of PqsR (PQS-binding response regulator) and inhibits pqs expression which is associated with pyocyanin (quorum sensing molecule) and the virulence thereafter (Mok et al. 2020) . Vanillin can, therefore, be explored to evaluate its antibiofilm properties against other biofilm-forming bacteria which are usually found resistant to antibacterial agents.

Vanillin is used as a natural crosslinker to fabricate chitosan hydrogel for wound healing. Self-healing chitosan-vanillin hydrogel is developed based on Schiff base and hydrogen bond hybrid linkages between chitosan and vanillin . At the atomic level, aldehyde moiety of vanillin reacts with amino group of one chitosan molecule through Schiff-base reaction and its hydroxyl moiety forms hydrogen bond with the hydroxyl or the amino groups in another chitosan molecule. The self-healing effect is generated by reconstruction of Schiffbase bond. Along with wound healing, rat skin samples treated with chitosan-vanillin membrane showed angiogenic stimulus, collagen deposition, re-epithelialization, and reduced levels of IL-1β and TNF-α as well as increased IL-10 and gene expression of TGF-β and VEGF (de Aragão Tavares et al. 2018) . Various concentrations of vanillin/chitosan along with other metallic and organic components are used for wound healing and tissue engineering such as osteochondral tissues (Hunger et al. 2019) . Although chitosan-vanillin hydrogels have promising outcomes for wound healing and tissue engineering, these studies are yet to be replicated in human and therefore clinical trials are needed to determine their applicability.

A novel vanillin derivative MY21 was designed, synthesized and evaluated for its anti-neuraminidase (NA) activity (Hariono et al. 2016) . Vanillin with guanidino group (MY21) at the C3 position played a vital role in NA inhibition. Modelling studies suggested that these predicted activities might be due to the interaction with conserved and essential residues of NA with ∆G bind (binding affinity of the ligand to the active site of the receptor) values comparable to those of oseltamivir and zanamivir, two commercially available NA inhibitors. Recently reports on SARS-CoV-2 suggests that vanillin has moderate affinity towards spike protein and main protease. Thus, further studies should be undertaken to enhance the inhibitory potential of vanillin and its derivative on SARS-CoV-2. Altogether, such findings suggest that vanillin and its derivatives can become suitable starting compounds for further lead optimization as NA inhibitors.

Vanillin is used in many cosmeceuticals owing to its fragrance and antioxidant properties. At non-toxic concentrations, vanillin was found to up-regulate the stemness mediators Oct-4, pOct-4 and Nanog (transcription factors that control the stem cell signatures in humans) and it also increased the expression of epithelial adhesive protein (E-cadherin) (Taboonpong et al. 2017) . Vanillin decreased the production of pro-inflammatory cytokines and reduced UV-B induced phosphorylation of ataxia telangiectasia mutated (ATM), serine-threonine kinase checkpoint kinase 2 (Chk2), tumor suppressor protein 53 (p53), p38/mitogen-activated protein kinase (p38), c-Jun N-terminal kinase/stressactivated protein kinase (JNK), S6 ribosomal protein (S6RP), and histone 2A family member X (H2A.X) (Lee et al. 2014 ). All these factors play a central role in skin renewal and repair; therefore, using vanillin or its derivatives as cosmeceutical ingredients could also provide therapeutic benefit in addition to providing fragrant and antioxidant effects.

So far, only a few clinical trials with vanilla or vanillin have been undertaken or completed. The details of these studies are summarized in Table 3 . However, only one out of these clinical trials was directed to assess the therapeutic potential of vanilla, while others were aimed to study the calming effect of vanilla/vanillin fragrance on the distressed infants with neonatal hypoxia and temporary Apnoea. Although few in numbers, these trails suggest that it is time to work towards and realize the therapeutic potential of vanilla/vanillin. The increase in the number of reports on the cyto-, neuro, nephron-, cardio-, and hepatoprotective potential of vanillin may therefore enhance the chances of vanillin to be considered for clinical trials in the future.

The bioavailability and hydrophobicity limit the bioactive efficiency and pharmacokinetics of vanillin. Nanocarriers or nanoparticles (NPs) can potentiate the bioactive profile of vanillin (Fig. 3) . Various reports are available were vanillin is either capped /functionalized onto the NPs (Table 4 ). These NPs also allow controlled/sustained release to prolong the effect of vanillin. Apart from delivering vanillin using NPs, vanillin itself can be used to synthesize NPs for the delivery of other drug molecules (Table 4) . It is an interesting development that a popular and one of the oldest flavoring molecule vanillin has found applications in the latest nanotechnology discipline as well. Due to these developments, it is essential to realize the potential of vanillin and consider it for therapeutic purposes. 

To date, vanillin has been utilized primarily as a flavour and fragrance ingredient. As discussed in this review, vanillin has shown diverse bioactivities that can be harnessed for human, animal and agricultural benefits. As it exhibited non-toxic effects in rat models, it is likely that vanillin is efficiently assimilated and eliminated from their bodies. Future studies in nanocarrier systems for vanillin may increase its stability, bioavailability and bioactivity. Hence with some promising inroads in this area, it would be interesting to systematically investigate the possible effects of vanillin with the multi-omics approach at cellular and molecular levels. This will enable us to further assess its applicability as an active biopharmaceutical ingredient to tackle important issues like neurodegeneration, antibiotic resistance, sicklecell anaemia, tissue engineering, viral infections and industrial applications such as food preservation.

Vanillin, a potential agent for the treatment of sickle cell anemia

Synergistic antioxidant capacities of vanillin and chitosan nanoparticles against reactive oxygen species, hepatotoxicity, and genotoxicity induced by aging in male Wistar rats

Vanillin: a comprehensive review of pharmacological activities

Vanillin mediated green synthesis and application of gold nanoparticles for reversal of antimicrobial resistance in Pseudomonas aeruginosa&nbsp

Vanilla modulates the activity of antibiotics and inhibits efflux pumps in drug-resistant Pseudomonas aeruginosa

Vanillin a food additive ameliorates harmaline induced tremor in rats

Vanillin restrains non-enzymatic glycation and aggregation of albumin by chemical chaperone like function

Vanillin biotechnology: the perspectives and future

Pharmacokinetics of vanillin and its effects on mechanical hypersensitivity in a rat model of neuropathic pain

Effects of vanillin on potassium bromate-induced neurotoxicity in adult mice: impact on behavior, oxidative stress, genes expression, inflammation and fatty acid composition

Vanillin selectively modulates the action of antibiotics against resistant bacteria

Overview of the role of vanillin on redox status and cancer development

Therapeutic potential of vanillin and its main metabolites to regulate the inflammatory response and oxidative stress

Synthesis and in vitro evaluation of vanillin derivatives as multi-target therapeutics for the treatment of Alzheimer's disease

Species-specific activity of antibacterial drug combinations

Bioengineering of the plant culture of Capsicum frutescens with vanillin synthase gene for the production of vanillin

Vanillin ameliorates changes in HIF-1 α expression and neuronal apoptosis in a rat model of spinal cord injury

Vanillin: the case for greener production driven by sustainability megatrend

Delivery of vanillin by poly (lactic-acid) nanoparticles: development, characterization and in vitro evaluation of antioxidant activity

Evaluation of chelating and cytoprotective activity of vanillin against the toxic action of mercuric chloride as an alternative for phytoremediation

Chitosan membrane modified with a new zinc (II)-vanillin complex improves skin wound healing in diabetic rats

Development of Rifampicin loaded Chitosan nanoparticles by 32 full Factorial design

Neurosupportive role of vanillin, a natural phenolic compound, on rotenone induced neurotoxicity in SH-SY5Y neuroblastoma cells. Evid Based Complem Altern Med

Production of starch nanoparticles by electrospraying as a delivery system for Vanillin

Electrosprayed core-shell polymer-lipid nanoparticles for active component delivery

Facile synthesis of chitosan-coated silica nanocapsules via interfacial condensation approach for sustained release of vanillin

Mode of antimicrobial action of vanillin against Escherichia coli, Lactobacillus plantarum and Listeria innocua

Naringenin and vanillin mitigate cadmium-induced pancreatic injury in rats via inhibition of JNK and p38 MAPK

Vanilla: the most popular flavour

Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease

Vanillin protects the blood-milk barrier and inhibits the inflammatory response in LPS-induced mastitis in mice

Differential immunomodulatory effect of graphene oxide and vanillinfunctionalized graphene oxide nanoparticles in human acute monocytic leukemia cell line (THP-1)

Effects of o-vanillin on K + transport of red blood cells from patients with sickle cell disease

Biphasic sonoelectroanalysis: simultaneous extraction from, and determination of vanillin in food flavoring

Potential new H1N1 neuraminidase inhibitors from ferulic acid and vanillin: molecular modelling, synthesis and in vitro&nbsp

Toxicology study of vanillin on rats via oral and intra-peritoneal administration

Double crosslinking of chitosan/vanillin as a basis to mechanically strong gradient hydrogel scaffolds for cartilage tissue engineering

Synthesis, antibacterial activity and molecular docking study of vanillin derived 1, 4-disubstituted 1, 2, 3-triazoles as inhibitors of bacterial&nbsp

Vanillin affects amyloid aggregation and nonenzymatic glycation in human insulin

Homodimers of vanillin and apocynin decrease the metastatic potential of human cancer cells by inhibiting the FAK/PI3K/Akt signaling pathway

Curcumin drug delivery by vanillinchitosan coated with calcium ferrite hybrid nanoparticles as carrier

Encapsulation of vanillin/cyclodextrin inclusion complex in electrospun polyvinyl alcohol (PVA) nanowebs: prolonged shelf-life and high temperature stability of vanillin

Vanillin, 4-hydroxybenzyl aldehyde and 4-hydroxybenzyl alcohol prevent hippocampal CA1 cell death following global ischemia

A vanillin derivative causes mitochondrial dysfunction and triggers oxidative stress in Cryptococcus neoformans

Anti-neuroinflammatory effects of vanillin through the regulation of inflammatory factors and NF-κB signaling in LPS-stimulated microglia

Study on the extraction of vanillin from vanilla planifolia Andr. with supercritical CO_2 Fluid

Inflammation-responsive antioxidant nanoparticles based on a polymeric prodrug of vanillin

Neuroprotective effect of Vanillin on hypoxicischemic brain damage in neonatal rats

Vanillin protects human keratinocyte stem cells against ultraviolet B irradiation

Development of drug-loaded chitosan-vanillin nanoparticles and its cytotoxicity against HT-29 cells

Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base

Vanillin-ameliorated development of azoxymethane/dextran sodium sulfate-induced murine colorectal cancer: the involvement of proteasome/nuclear factor-κB/mitogen-activated protein kinase pathways

Vanillin derivative VND3207 activates DNA-PKcs conferring protection against radiation-induced intestinal epithelial cells injury in vitro and in vivo

Inhibitory effect of vanillin on the virulence factors and biofilm formation of Hafnia alvei

Anti-angiogenic, anti-inflammatory and anti-nociceptive activities of vanillin in ICR mice

A vanillin derivative suppresses the growth of HT29 cells through the Wnt/β-catenin signaling pathway

IPM712, a vanillin derivative as potential antitumor agents, displays better antitumor activity in colorectal cancers cell lines

Toxicity of vanillin Gigiena i Sanitariya

Vanillin inhibits PqsRmediated virulence in Pseudomonas aeruginosa

Ortho-vanillin nanoparticledoped glucan microspheres exacerbate the anti-arthritic effects of methotrexate in adjuvant-induced arthritis in rats

Evidence of vanillin binding to CAMKIV explains the anti-cancer mechanism in human hepatic carcinoma and neuroblastoma cells

Antimicrobial activity of vanillin against spoilage microorganisms in stored fresh-cut mangoes

Rational design of pyridyl derivatives of vanillin for the treatment of sickle cell disease

Proteomic profiling, transcription factor modeling, and genomics of evolved tolerant strains elucidate mechanisms of vanillin toxicity in Escherichia coli

In silico screening of food bioactive compounds to predict potential inhibitors of COVID-19 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)

Inhibition of quorum sensing mechanism and Aeromonas hydrophila biofilm formation by vanillin

Deciphering the interaction of food additive, vanillin with DNA: A biophysical and computational study

Vanillin extracted from Proso and Barnyard millets induce apoptotic cell death in HT-29 human colon cancer cell line Nutr Cancer

Fabrication of electrospun almond gum/PVA nanofibers as a thermostable delivery system for vanillin

Antifungal activity of vanilla juice and vanillin against Alternaria alternata

In silico investigation of spice molecules as potent inhibitor of SARS-CoV-2

Mechanistic insights into the anticandidal action of Vanillin reveal disruption of cell surface integrity and mitochondrial functioning

Vanillin and vanillic acid modulate antioxidant defense system via amelioration of metabolic complications linked to Fe 2+-induced brain tissues damage

Microwave-and ultrasound-assisted extraction of vanillin and its quantification by high-performance liquid chromatography in Vanilla planifolia

An overview of therapeutic effects of vanillic acid

Nephroprotective effect of vanillic acid against cisplatin induced nephrotoxicity in wistar rats: a biochemical and molecular study

Vanilla: potential health benefits

Vanillin prevents doxorubicininduced apoptosis and oxidative stress in rat H9c2 cardiomyocytes

Analysis of the volatile components in vanilla extracts and flavorings by solid-phase microextraction and gas chromatography

Radiation-induced H3K9 tri-methylation in E-cadherin promoter during lung EMT: in vitro and in vivo approaches using Vanillin

Vanillin increases stem cell signal and cell adhesion in keratinocytes

Antioxidant properties of ethyl vanillin in vitro and in vivo

Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays Biochimica

The story of vanilla. In: Orchids as aphrodisiac, medicine or food

Anti-quorum sensing activity of natural compounds against Chromobacterium violaceum

Efficiency of vanillin in impeding metabolic adaptability and virulence of Candida albicans by inhibiting glyoxylate cycle, morphogenesis, and biofilm formation

Determination of glucovanillin and vanillin in cured vanilla pods

Effect of hydration and enzymatic pretreatment of vanilla beans on the kinetics of vanillin extraction

Novel vanillin derivatives containing a 1, 3, 4-thiadiazole moiety as potential antibacterial agents

Self-healing chitosan/vanillin hydrogels based on Schiff-base bond/hydrogen bond hybrid linkages

Vanillin protects dopaminergic neurons against inflammation-mediated cell death by inhibiting ERK1/2, p38 and the NF-κB signaling pathway

Vanillin enhances the passive transport rate and absorption of drugs with moderate oral bioavailability in vitro and in vivo by affecting the membrane structure

Modulation of NADPH oxidase and Nrf2/HO-1 pathway by vanillin in cisplatin-induced nephrotoxicity in rats

Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats

Comparative analysis of volatiles in traditionally cured Bourbon and Ugandan vanilla bean (Vanilla planifolia) extracts

Preparation of nanoparticles by crosslinking folate conjugated chitosan with vanillin and its characterization

The authors are thankful to the TERI-Deakin